INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL. (12th June 2019) - Jaeger, U.; Tam, C.; Borchmann, P.; McGuirk, J.; Holte, H.; Waller, E.; Jaglowski, S.; Andreadis, C.; Foley, S.R.; Fleury, I.; Westin, J.; Teshima, T.; et al.